Closed
Source verified July 8, 2026
Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025
AI life sciences business mission
Funding available
Varies by project
Deadline
June 15, 2025
Location
Canada
Overview
Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 is open to small and medium-sized enterprises and supports a South Korea-focused co-innovation mission in AI in life sciences. Eligible areas include AI in drug discovery, clinical trial management and optimization, and predictive analytics in healthcare.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Conduct research and development activities
- Access new markets
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- AI in drug discovery, including target identification and molecule generation; clinical trial management and optimization; predictive analytics in healthcare and personalized medicine; data platforms enabling AI-driven R&D; advanced applications of AI across the pharmaceutical value chain; application of AI in biomanufacturing of advanced therapeutics.
Official resources
Eligibility
Who is eligible?
- Small and medium-sized enterprises
Additional information
- This page is archived and will not be updated.
- Related program: Canadian International Innovation Program.
Contacts
Other components of this program
Explore related funding streams and grants that belong to the same program.
- Battery Production Technology R&D Partnering Mission to Germany – February 19-23, 2024R&D mission for battery technology SMEs
- Canada – Singapore 2025-26 collaborative industrial research and development call for proposalsBilateral support for Singapore-Canada R&D collaboration
- Canada – South Korea 2022 collaborative industrial research and development call for proposalsBilateral industrial R&D collaboration support
- Canada – South Korea co-innovation 2025 call for proposalsCross-border innovation collaboration support
- Canada-China collaborative industrial research and development call for proposals 2019-20Canada-China industrial R&D collaboration support
- Canada-India 2020 collaborative industrial research and development call for proposalsBilateral R&D collaboration support
- Canada-India 2024-25 collaborative industrial research and development call for proposalsBilateral industrial R&D collaboration support
- Canada-South Korea 2024 Call for ProposalsCanada-South Korea collaborative industrial R&D support
- Canada–Brazil (EMBRAPII) 2023 collaborative industrial research and development call for proposalsCollaborative industrial R&D for Canadian and Brazilian firms
- Canada–Taiwan 2024-2025 collaborative industrial research and development call for proposalsCross-border industrial R&D collaboration support
Frequently Asked Questions about the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 Program
What is the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025?
Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 is open to small and medium-sized enterprises and supports a South Korea-focused co-innovation mission in AI in life sciences. Eligible areas include AI in drug discovery, clinical trial management and optimization, and predictive analytics in healthcare.
Who is eligible for the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 program?
To be eligible for the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 program, you must:
The applicant must be a small or medium-sized enterprise.
What expenses are eligible under Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025?
AI in drug discovery, including target identification and molecule generation; clinical trial management and optimization; predictive analytics in healthcare and personalized medicine; data platforms enabling AI-driven R&D; advanced applications of AI across the pharmaceutical value chain; application of AI in biomanufacturing of advanced therapeutics.
Who can I contact for more information about the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025?
You can contact National Research Council Canada (NRC) by email at none or by phone at none.
Where is the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 available?
The Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 program is available across Canada.
Is the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 a grant, loan, or tax credit?
Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 is a Partnering and Collaboration
Who are the financial supporters of the Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025?
Canadian AI in Life Sciences co-innovation mission to South Korea – September 23-25, 2025 is funded by National Research Council Canada (NRC)